Royalty Pharma plc (RPRX) is higher by Monday morning, with the stock adding 2.26% in pre-market trading to 42.5. RPRX's short-term technical score of 55 indicates that the stock has traded more bullishly over the last month than 55% of stocks on the market. In the Biotechnology industry, which ranks 138 out of 146 industries, Royalty Pharma plc ranks higher than 84% of stocks. Royalty Pharma plc has risen 10.83% over the past month, closing at $37.67 on October 25. During this period of time, the stock fell as low as $36.81 and as high as $43.68. RPRX has an average analyst recommendation of Strong Buy. The company has an average price target of $51.71.
RPRX has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on RPRX!